Literature DB >> 9764360

Regulation of major histocompatibility complex and TAP gene products in preimplantation mouse stage embryos.

J C Cooper1, N Fernandez, E Joly, G B Dealtry.   

Abstract

PROBLEM: To determine the ontogeny of major histocompatibility complex (MHC) expression and TAP products in mouse embryos. METHOD OF STUDY: mRNAs encoding MHC and associated molecules were identified by reverse transcriptase-polymerase chain reaction, and the protein products were localized by confocal microscopy.
RESULTS: mRNAs encoding class Ia (H-2Db) and class Ib (Q7/9) were present in one-cell embryos, whereas beta 2-microglobulin (beta 2-m) transcripts were not detected until the two-cell stage. Transporter TAP1, but not TAP2, transcripts were detected only in blastocysts. H-2 class Ia (classical) protein was detected on the surface of two-cell embryos, H-2 class Ib (nonclassical) protein was detected on one-cell embryos, and beta 2-m transcripts were detected on eight-cell embryos; TAP1 protein was present at low levels in the cytoplasm from the one-cell stage onward, increasing in expression in blastocysts.
CONCLUSIONS: In mice, MHC class I mRNAs encoding the heavy chain of H-2- and Q7/9-encoding Qa2 molecules are synthesized soon after conception prior to implantation. Similarly, the nonpolymorphic MHC class I-associated molecule beta 2-m also is expressed before implantation. TAP1, but not TAP2, is first detected at the blastocyst stage, thus preceding the onset of TAP2 in embryonic development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764360     DOI: 10.1111/j.1600-0897.1998.tb00408.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  4 in total

1.  A corpus luteum is not a prerequisite for the expression of progesterone induced blocking factor by T-lymphocytes a week after implantation.

Authors:  J H Check; J Szekeres-Bartho; P Nazari; Y Katz; M L Check
Journal:  J Assist Reprod Genet       Date:  2001-11       Impact factor: 3.412

Review 2.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Authors:  Chad Tang; Micha Drukker
Journal:  Semin Immunopathol       Date:  2011-04-11       Impact factor: 9.623

3.  The role of tapasin in MHC class I protein trafficking in embryos and T cells.

Authors:  Paula W Lampton; Carmit Y Goldstein; Carol M Warner
Journal:  J Reprod Immunol       Date:  2007-12-03       Impact factor: 4.054

Review 4.  Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives.

Authors:  Chad Tang; Irving L Weissman; Micha Drukker
Journal:  Methods Mol Biol       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.